From: Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
 | Training set | Validation set | ||
---|---|---|---|---|
Demographic | Glioma (n=65) | Control (n=38) | Glioma (n=66) | Control (n=39) |
Age | Â | Â | Â | Â |
  Mean | 46.6 | 47.6 | 49.2 | 51.2 |
  Range | 12-74 | 34-68 | 24-78 | 22-77 |
Sex | Â | Â | Â | Â |
  Male | 40 | 21 | 37 | 21 |
  Female | 25 | 17 | 29 | 18 |
WHO grade | Â | Â | Â | Â |
  I | 7 |  | 8 |  |
  II | 28 |  | 29 |  |
  III | 9 |  | 9 |  |
  IV | 21 |  | 20 |  |